About this episode
A week ago, the Biden administration announced support for waiving intellectual property protection for Covid-19 vaccines. In response, Bio, a trade association representing biotechnology companies, issued a statement saying, "The United States has unfortunately chosen to set a dangerous precedent with these actions.” This week on Intercepted: Intercept investigative journalists Sharon Lerner and Lee Fang discuss how the pharmaceutical industry has ruthlessly fought to maintain IP protection from the beginning of the pandemic despite global calls to share knowledge and know-how to end the crisis as quickly as possible. By claiming the same monopoly IP rights on Covid-19 therapeutics and vaccines as other drugs, the industry has perpetuated a market of scarcity and profiteering when a collaborative global response is needed.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time The Intercept Briefing publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Intercept Briefing
Another Assassination Attempt, More Fertilizer for Conspiracy Theories
The Intercept Briefing
May 1, 202646:45failed
“Me Too” Comes Back To Congress
The Intercept Briefing
Apr 24, 202635:20failed
When Anti-War Candidates Become War-Monger Presidents
The Intercept Briefing
Apr 17, 202644:46failed
Amy Goodman on the Media’s “Access of Evil”
The Intercept Briefing
Apr 14, 202632:12failed